CHAUDHURI BHASKAR 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) Director Bhaskar Chaudhuri Receives 2,954 Shares (RSU)
What Happened
Bhaskar Chaudhuri, a director of Tarsus Pharmaceuticals, had 2,954 restricted stock units (RSUs convertibles to common shares) vest on June 12, 2026 and those RSUs were converted into 2,954 shares. The filing also shows a simultaneous disposition of 2,954 shares at $0.00 (no cash proceeds reported). This was an RSU settlement/derivative conversion rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-12 (reported on Form 4 filed 2026-06-16).
- Reported transactions: conversion/exercise of derivative (code M) — 2,954 shares acquired; 2,954 shares disposed at $0.00.
- Price/Value: acquisition shows N/A; disposition shows $0.00 (no cash proceeds reported in the filing).
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Footnotes: shares were issued pursuant to settlement of vested RSUs granted June 12, 2025 that vested in full on the one‑year anniversary, subject to continuous service.
- Timeliness: filing appears timely (transaction 6/12/2026; filed 6/16/2026).
Context
RSUs are compensation that convert to shares when they vest. It’s common for insiders to have shares withheld or surrendered to cover taxes at vesting; the filing shows a disposition at $0, which likely reflects internal withholding rather than an open‑market sale. Such RSU settlements are routine compensation events and do not necessarily signal a change in insider sentiment.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-12+2,954→ 11,654 total - Exercise/Conversion
Restricted Stock Units
[F2][F3]2026-06-12−2,954→ 0 total→ Common Stock (2,954 underlying)
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.